𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression profiling of ETS and MMP factors in VEGF-activated endothelial cells: Role of MMP-10 in VEGF-induced angiogenesis

✍ Scribed by Sun-Hee Heo; Young-Jin Choi; Hyun-Mo Ryoo; Je-Yoel Cho


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
320 KB
Volume
224
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

In the process of angiogenesis, working of many transcription factors at the proper time is important to activate angiogenesis‐related genes such as cytokine, matrix protease and adhesion molecules. In this study, we searched for Ets transcription factors and matrix metalloproteinases (MMPs) that respond to VEGF in endothelial cells. We first analyzed the expression of 27 human Ets factors and 15 human MMPs in VEGF‐treated human umbilical vein endothelial cells (HUVEC) using quantitative RT‐PCR. The most abundant Ets factors in HUVEC were ETS‐1, Fli‐1, ERP/NET/ELK3, and ERG. MMP‐1, ‐2, ‐10, ‐11, ‐14, ‐15, and ‐16 were also detected in HUVEC. We also found that ETV‐1, Fli‐1, ERG, MMP‐1, ‐3, ‐7, ‐8, ‐9, ‐10, ‐13, and ‐19 expression is up‐regulated more than 1.5‐fold in HUVEC after 2 h of VEGF treatment. In addition, the expression of MMP‐10 induced by VEGF remained twofold higher for 24 h compared to non‐treated control. The elevation of MMP10 mRNA and protein levels was confirmed to be both time‐ and dosage‐dependent. In addition, MMP‐10 transcription was mediated by Ets‐1 but not ERP/NET/ELK3. The inhibition of PI3K and MAPK inhibited VEGF‐induced MMP‐10 expression. Furthermore, transfection of MMP‐10 siRNA inhibited VEGF‐induced migration and tube formation in HUVEC, and it also inhibited vessel formation in matrigel plugs in vivo. In conclusion, our study demonstrated induction of MMP‐10 by VEGF in HUVEC and supports an angiogenic role for MMP‐10 in response to VEGF stimulation in vitro and in vivo. J. Cell. Physiol. 224: 734–742, 2010. © 2010 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Differential role of β-catenin in VEGF a
✍ Jennifer L. Doyle; Tara L. Haas 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB

## Abstract Increases in endothelial cell permeability and production of matrix‐degrading enzymes are two early steps in the angiogenic process. Factors such as vascular endothelial growth factor (VEGF) and histamine induce the angiogenic process through alterations in both permeability and proteol

Vascular endothelial growth factor (VEGF
✍ Michael S. Pepper; Stefano J. Mandriota; Michael Jeltsch; Vijay Kumar; Kari Alit 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 689 KB

Vascular endothelial growth factor-C (VEGF-C) is a recently characterized member of the VEGF family of angiogenic polypeptides. We demonstrate here that VEGF-C is angiogenic in vitro when added to bovine aortic or lymphatic endothelial (BAE and BLE) cells but has little or no effect on bovine microv

Expression of vascular endothelial growt
✍ Decaussin, Myriam; Sartelet, Herv�; Robert, Catherine; Moro, Denis; Claraz, Chri 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 3 views

The formation of new vessels (angiogenesis) is essential for primary tumour growth and metastasis and is induced by several angiogenic factors, including vascular endothelial growth factor (VEGF). The microvascular density (MVD) in tumours was assessed and the expression of VEGF and its receptors VE

Interleukin-6 induces transcriptional ac
✍ Sébastien Loeffler; Bérengère Fayard; Joachim Weis; Jakob Weissenberger 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 780 KB

## Abstract Interleukin‐6 (IL‐6) expression is strongly correlated with the degree of human glioma malignancy and necessary for tumor formation in a mouse model of spontaneous astrocytomas. Yet, exactly how IL‐6 contributes to malignant progression of these brain tumors is still unclear. We have sc